ZIM Laboratories is all set to get listed on the National Stock Exchange (NSE) on November 25, 2022. The company is already listed on the BSE since June 2018, will now extend its listing to the NSE. As on date, has provided over 85% return to its investors from the listing price.
The company has multiple innovative process technologies like Micro Emulsion Coating Technology (MECT) (Liquid In Pellets), Pellet Cold Forming Technology (PCFT), Rapid Gelation Drug Release Technology (RGDCT), Matrix Pore Forming Tablet Technology (MAPOTAB) etc., which it leverages to develop innovative generic pharmaceutical products including Oral Thin Films (OTF) using its patented Thinoral technology.
ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develops generic pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: